AKT1 and neoplasm: LINC01419 silencing inhibits the activation of the PI3K/AKT1/mTOR pathway, as demonstrated by reduced phosphorylation of AKT1 and mTOR, thus promoting autophagy of GC cells as well as inhibiting tumor growth and metastasis.